For the quarter ended December 2025, Patterson-UTI (PTEN) reported revenue of $1.15 billion, down 1% over the same period last year. EPS came in at -$0.02, compared to -$0.12 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.1 billion, representing a surprise of +4.65%. The company delivered an EPS surprise of +81.82%, with the consensus EPS estimate being -$0.11.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Patterson-UTI performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Patterson-UTI here>>>
Shares of Patterson-UTI have returned +15.7% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Aug-14 | |
| Aug-12 | |
| Jul-30 | |
| Jul-30 | |
| Jul-29 | |
| Jul-29 | |
| Jul-14 | |
| Jul-09 | |
| Jul-06 | |
| Jun-05 | |
| May-07 | |
| May-06 | |
| Apr-24 | |
| Apr-23 | |
| Apr-22 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite